{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T10:27:45Z","timestamp":1766658465079,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.arbres.2025.04.013","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T18:28:57Z","timestamp":1745692137000},"page":"626-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating the Utility of Biologic Therapies in Patients With Severe Asthma and Comorbid Bronchiectasis: A Systematic Review With Meta-analysis of Retrospective Studies"],"prefix":"10.1016","volume":"61","author":[{"given":"Ignasi","family":"Garcia-Oliv\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Radua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Hernandez Biette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Bruguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Sanchez Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Mart\u00ednez Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2025.04.013_bib0110","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1183\/13993003.00289-2016","article-title":"Bronchiectasthma and asthmectasis!","volume":"47","author":"Soriano","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2025.04.013_bib0115","doi-asserted-by":"crossref","first-page":"22820","DOI":"10.1038\/s41598-021-02332-w","article-title":"Risk factors for the development of bronchiectasis in patients with asthma","volume":"11","author":"Ma","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.arbres.2025.04.013_bib0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12931-018-0746-7","article-title":"Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients","volume":"19","author":"Padilla-Galo","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2025.04.013_bib0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.anai.2018.02.016","article-title":"Bronchiectasis in severe asthma: clinical features and outcomes","volume":"120","author":"Coman","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.arbres.2025.04.013_bib0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02770903.2019.1579832","article-title":"Severe asthma and bronchiectasis","volume":"57","author":"Garc\u00eda-Clemente","year":"2020","journal-title":"J Asthma"},{"key":"10.1016\/j.arbres.2025.04.013_bib0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4168\/aair.2024.16.3.291","article-title":"The impact of bronchiectasis on the clinical characteristics of non-severe asthma","volume":"16","author":"Han","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.arbres.2025.04.013_bib0140","doi-asserted-by":"crossref","first-page":"230238","DOI":"10.1183\/16000617.0238-2023","article-title":"Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Kyriakopoulos","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.arbres.2025.04.013_bib0145","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12890-023-02786-w","article-title":"Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study","volume":"23","author":"Al-Ahmad","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.arbres.2025.04.013_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2023.05.041","article-title":"Real-world effectiveness of IL-5\/5Ra targeted biologics in severe eosinophilic asthma with comorbid bronchiectasis","volume":"11","author":"Bendien","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.arbres.2025.04.013_bib0155","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neubiorev.2021.02.016","article-title":"PRISMA 2020 \u2013 an updated checklist for systematic reviews and meta-analyses","volume":"124","author":"Radua","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.arbres.2025.04.013_bib0160","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","volume":"29","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.arbres.2025.04.013_bib0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/JAA.S196200","article-title":"Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab","volume":"12","author":"Carpagnano","year":"2019","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.arbres.2025.04.013_bib0170","doi-asserted-by":"crossref","first-page":"106491","DOI":"10.1016\/j.rmed.2021.106491","article-title":"Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: a real-world retrospective pilot study","volume":"185","author":"Crimi","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2025.04.013_bib0175","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/biomedicines9070772","article-title":"T2-high endotype and response to biological treatments in patients with bronchiectasis","volume":"9","author":"Oriano","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.arbres.2025.04.013_bib0180","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.anai.2020.11.014","article-title":"Efficacy of type 2-targeted biologics in patients with asthma and bronchiectasis","volume":"126","author":"Kudlaty","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.arbres.2025.04.013_bib0185","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.3390\/jcm12123953","article-title":"Benralizumab effectiveness in severe eosinophilic asthma with co-presence of bronchiectasis: a real-world multicentre observational study","volume":"12","author":"Campisi","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.arbres.2025.04.013_bib0190","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1159\/000511459","article-title":"Bronchiectasis in severe asthma: does it make a difference?","volume":"99","author":"Bendien","year":"2020","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2025.04.013_bib0195","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.3390\/jcm13216309","article-title":"Clinical remission predictors in non-colonized bronchiectasis and severe asthma with type 2-targeted biologic therapy: a retrospective real-life pilot study","volume":"13","author":"Quaranta","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.arbres.2025.04.013_bib0200","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/cea.14026","article-title":"Effectiveness of benralizumab in severe eosinophilic asthma: distinct sub-phenotypes of response identified by cluster analysis","volume":"52","author":"Di Bona","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.arbres.2025.04.013_bib0205","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1016\/j.jaip.2024.08.033","article-title":"Long-term clinical and sustained remission in severe eosinophilic asthma treated with mepolizumab: the REMI-M study","volume":"12","author":"Crimi","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.arbres.2025.04.013_bib0210","doi-asserted-by":"crossref","first-page":"1343362","DOI":"10.3389\/fimmu.2024.1343362","article-title":"Features of severe asthma response to anti-IL5\/IL5r therapies: identikit of clinical remission","volume":"15","author":"Carpagnano","year":"2024","journal-title":"Front Immunol"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289625001498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289625001498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T22:14:47Z","timestamp":1759875287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289625001498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0300289625001498"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2025.04.013","relation":{},"ISSN":["0300-2896"],"issn-type":[{"type":"print","value":"0300-2896"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the Utility of Biologic Therapies in Patients With Severe Asthma and Comorbid Bronchiectasis: A Systematic Review With Meta-analysis of Retrospective Studies","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2025.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}